Johnson & Johnson makes progress in coronavirus vaccine research

“We have a potential vaccine that is very likely to be effective against coronavirus. We have the opportunity to increase its production in a relatively short time,” Johnson & Johnson boss Alex Gorsky told NBC.

The company maintains that if the vaccine proved to be effective, it could appear on the market early next year and its price would not be excessive. Johnson & Johnson would then like to produce one billion vaccines by the end of 2021.